Roughly 6 out of every 100 people who catch COVID-19 go on to develop long COVID, according to global estimates from the World Health Organization. In the United States, about 6% of all adults reported living with long COVID symptoms as of mid-2023, down from 7.5% the year before. Those numbers translate to millions of people dealing with symptoms that persist for months or longer after their initial infection.
What Counts as Long COVID
Long COVID is defined as a chronic condition that develops after a COVID-19 infection and lasts at least three months. Symptoms vary widely, but the most frequently reported ones are fatigue, pain, and memory problems. Some people experience mild ongoing issues, while others face significant limitations in daily activities like work, exercise, or household tasks.
How Often Infections Lead to Long COVID
Among Americans who reported having had COVID-19, about 11% said they went on to develop long COVID, based on 2023 survey data from the CDC. That rate had dropped from nearly 19% a year earlier, likely reflecting a combination of factors: newer variants, wider vaccination, and repeated prior infections building some immune familiarity.
Children and young adults develop long COVID too. Estimates suggest 10% to 20% of kids who get infected experience prolonged symptoms, according to research funded by the National Heart, Lung, and Blood Institute. That range is broad partly because defining and measuring long COVID in children is harder. Kids may struggle to articulate what they’re feeling, and some symptoms overlap with normal childhood complaints like tiredness or difficulty concentrating.
Severity of Initial Illness Matters Less Than You’d Think
One of the more counterintuitive findings is that being hospitalized with a severe case doesn’t necessarily make long COVID more likely. A study following patients in Madrid found that nearly 60% of hospitalized patients and 68% of those who recovered at home still had at least one persistent symptom two years later. Fatigue was the most common complaint in both groups (about 45% to 48%), followed by pain (30% to 36%) and memory problems (16% to 20%). The differences between groups were not statistically significant.
This means a mild initial infection doesn’t protect you from developing long-term symptoms. Researchers believe the mechanisms driving long COVID, such as lingering inflammation and immune dysfunction, can be triggered regardless of how sick the virus initially made you.
The Omicron Shift
The variant you caught makes a meaningful difference. A large study published in The Lancet compared long COVID rates between the Delta and Omicron waves and found a substantial drop. About 10.8% of people infected during the Delta wave developed long COVID, compared to 4.5% during the Omicron wave. Depending on age and vaccination timing, Omicron infections carried 50% to 76% lower odds of leading to long COVID compared to Delta.
Since Omicron descendants have dominated globally since early 2022, this partly explains why overall long COVID rates have been trending downward. But 4.5% of an enormous number of infections still adds up quickly.
How Much Vaccination Helps
Vaccination significantly reduces the risk of developing long COVID if you do get infected. Analysis of available data shows that one dose reduced the risk by about 19%, two doses cut it by roughly 58%, and three doses lowered it by around 63%. The protection isn’t complete, but it’s substantial, particularly with a full primary series plus a booster.
This reduction appears to hold across different variants and age groups, making vaccination one of the most effective tools for lowering your personal risk of long-term symptoms beyond simply avoiding infection altogether.
Do People Recover?
Most people with long COVID do improve over time, but recovery is often slow and incomplete. A large population-based study published in The BMJ tracked people for up to two years after infection. At the 12-month mark, about 18.5% of those who had been infected reported they still hadn’t fully recovered. That means the majority did feel better within a year, but a significant minority continued to struggle well past that point.
Recovery timelines vary enormously from person to person. Some people see steady improvement over three to six months. Others plateau or experience symptoms that wax and wane unpredictably. Fatigue and cognitive difficulties (“brain fog”) tend to be among the slowest symptoms to resolve. There’s currently no single treatment that reliably speeds recovery, though managing individual symptoms, staying within your energy limits, and gradual rehabilitation all appear to help.
Putting the Numbers in Perspective
Long COVID is common enough that most people know someone affected by it, even if the overall percentage per infection has dropped since the early pandemic. With billions of COVID-19 infections worldwide, even a rate of 4% to 6% represents tens of millions of people. In the U.S. alone, the 6% adult prevalence figure from mid-2023 translates to roughly 15 million adults living with ongoing symptoms at that time.
Your individual risk depends on several overlapping factors: which variant you encountered, whether you were vaccinated (and how many doses you received), your age, and likely your underlying health, though that relationship is less straightforward than many assume. Repeated infections also appear to carry cumulative risk, meaning each new bout of COVID-19 offers another chance for long-term symptoms to develop.